PBH Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 birž. 2024 @ 23:00):
Our systems believe the stock currently is undervalued by 0.09% compare to its pairs and should correct upwards.

Stats
Šios dienos apimtis	479 918
Vidutinė apimtis	250 056
Rinkos kapitalizacija	3.42B
EPS	$0.990 ( Q4 \| 2024-05-15 )
Kita pelno data	( $0.870 ) 2024-08-01
Last Dividend	$0.475 ( 2018-09-27 )
Next Dividend	$0 ( N/A )
P/E	16.51 (Sector) 49.64 (Industry) 27.21
ATR14	$0.0530 (0.08%)

ABC -0.23%

CAH -1.31%

COR -1.17%

MCK -1.54%

OMI -1.75%

PBH -1.11%

Insider Trading

Date	Person	Action	Amount	type
2024-05-07	Lombardi Ronald M.	Buy	14 298	Common Stock, par value $0.01 per share
2024-05-07	Mekhail Adel	Buy	3 020	Common Stock, par value $0.01 per share
2024-05-07	Zerillo Jeffrey	Buy	2 116	Common Stock, par value $0.01 per share
2024-05-07	Sacco Christine	Buy	6 062	Common Stock, par value $0.01 per share
2024-05-07	P'pool William	Buy	3 123	Common Stock, par value $0.01 per share

INSIDER POWER
-2.39
Last 99 transactions
Buy: 314 062 \| Sell: 339 954

Koreliacija (AI algo v.1.1b): Undervalued: 0.09% $68.92 paired level. (Algoritmas realiuoju laiku stebi didžiausią koreliaciją turinčių akcijų pokyčius ir suteikia momentinę informaciją)

Tūris Koreliacija

Ilgas: 0.05 (neutral)

Trumpas: 0.78 (moderate)

Signal:(67.219) Neutral

Prestige Consumer Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
BWLP	0.968
PACS	0.945
OBDC	0.941
CNDA-UN	0.938
VLTO	0.92
ELME	0.918
NEE-PR	0.913
HAFN	0.912
AMBP	0.907
TFPM	0.899

10 Labiausiai neigiamai susiję koreliacijos
QBTS	-0.938
BYON	-0.929
MPU	-0.929
AMBI	-0.926
CIO	-0.914
CCG	-0.913
HR	-0.908
FLNG	-0.908
KW	-0.903
MKFG-WT	-0.902

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Prestige Consumer Koreliacija - Valiuta/Žaliavos

-0.74
( moderate negative )

0.19
( neutral )

0.00
( neutral )

0.39
( neutral )

-0.30
( neutral )

-0.42
( neutral )

Prestige Consumer Finansinės ataskaitos

Annual	2024
Pajamos:	$1.13B
Bruto pelnas:	$601.90M (53.48 %)
EPS:	$4.21

FY	2024
Pajamos:	$1.13B
Bruto pelnas:	$601.90M (53.48 %)
EPS:	$4.21

FY	2023
Pajamos:	$1.13B
Bruto pelnas:	$625.29M (55.45 %)
EPS:	$-1.650

FY	2022
Pajamos:	$1.09B
Bruto pelnas:	$620.65M (57.11 %)
EPS:	$4.09

Financial Reports:

Symbol	Period	Year	Title
PBH	FY	2024	Prestige Consumer Healthcare Inc Q4 2024 Financial Results

Prestige Consumer Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Prestige Consumer Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.54 - Potential for dividend initiation, but uncertain (10.83%)

Information

First Dividend	$0.475	2018-09-27
Last Dividend	$0.475	2018-09-27
Next Dividend	$0	N/A
Payout Date	2018-10-15
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	$0.475	--
Avg. Dividend % Per Year	0.00%	--
Score	2.51	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.54
Div. Directional Score	8.35	--

Next Divdend (Est)
(2024-07-01)

$0 Estimate 0.00 %

Dividend Stability

0.01 Very Bad

Dividend Score

2.51

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2018	$0.475	1.08%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Dividend History

Ex Date	Amount	Declaration Date	Record Date	Payment Date
27 Sep 2018	$0.475	30 Nov -0001	30 Nov -0001	15 Oct 2018

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
ECC	Dividend Diamond	2024-07-11	Monthly	11	14.91%	9.72
BRW	Dividend Diamond	2024-06-11	Monthly	33	9.41%	9.26
VVR	Dividend Diamond	2024-06-18	Monthly	27	8.85%	9.19
FCT	Dividend Diamond	2024-06-03	Monthly	21	8.33%	9.14
PHK	Dividend Diamond	2024-06-13	Monthly	22	9.07%	9.13
SBR	Dividend Diamond	2024-06-17	Monthly	38	9.57%	9.10
XFLT	Dividend Diamond	2024-06-17	Monthly	8	10.49%	9.09
SRV	Dividend Royal	2024-07-16	Monthly	18	10.61%	9.04
FAM	Dividend Royal	2024-06-03	Monthly	20	8.07%	8.98
RA	Dividend Diamond	2024-06-11	Monthly	9	10.10%	8.93

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.186	1.500	6.28	9.42	[0 - 0.5]
returnOnAssetsTTM	0.0624	1.200	7.92	9.51	[0 - 0.3]
returnOnEquityTTM	0.134	1.500	9.63	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	3.20	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	1.907	0.800	3.49	2.79	[0.8 - 2.5]
cashRatioTTM	0.397	1.500	8.91	10.00	[0.2 - 2]
debtRatioTTM	0.337	-1.500	4.38	-6.57	[0 - 0.6]
interestCoverageTTM	5.10	1.000	9.22	9.22	[3 - 30]
operatingCashFlowPerShareTTM	5.00	2.00	8.33	10.00	[0 - 30]
freeCashFlowPerShareTTM	4.80	2.00	7.60	10.00	[0 - 20]
debtEquityRatioTTM	0.684	-1.500	7.26	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.550	1.000	4.17	4.17	[0.2 - 0.8]
operatingProfitMarginTTM	0.304	1.000	5.91	5.91	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.220	1.000	9.89	9.89	[0.2 - 2]
assetTurnoverTTM	0.335	0.800	-1.098	-0.879	[0.5 - 2]
Total Score				11.15

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	16.39	1.000	8.45	0	[1 - 100]
returnOnEquityTTM	0.134	2.50	9.76	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	4.80	2.00	8.40	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	5.00	2.00	8.33	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	3.92	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.221	1.000	6.97	0	[0.1 - 0.5]
Total Score				5.54

Prestige Consumer Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Prestige Consumer

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.